LHX vs PTHS · P/E 34, rev $5.88B vs rev $16.8M
L3Harris Technologies Inc (LHX) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the LHX and PTHS stock pages for the full models.
Not investment advice.